Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

15.45
Delayed Data
As of 4:00pm ET
 +0.14 / +0.91%
Today’s Change
13.77
Today|||52-Week Range
119.87
-84.80%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues2.8B2.4B2.4B2.5B
 
 
 
 
 
Cost of Goods Sold658.8M577.6M626.3M614.5M
 
 
 
 
 
Depreciation And Amortization752.9M746.8M704.1M708.6M
 
 
 
 
 
 
Operating ExpensesGross Income1.3B1.0B1.1B1.2B
 
 
 
 
 
General Expenses815.8M915.7M795.8M761.7M
 
 
 
 
 
Other Operating Expenses42.9M5.1M4.7M1.1M
 
 
 
 
 
Research And Development95.9M103.1M124.3M100.8M
 
 
 
 
 
Total Operating Expenses2.3B2.2B2.1B2.1B
 
 
 
 
 
 
Non-Operating ExpensesOperating Income486.8M126.4M289.3M393.7M
 
 
 
 
 
Extraordinary Credit--0.0039.0M0.00
 
 
Extraordinary Charge-319.7M-42.2M-258.8M-1.3B
 
 
 
 
 
Interest Expense On Debt432.5M426.6M472.5M469.6M
 
 
 
 
 
Other Expenses-3.3M-24.2M24.1M-2.3M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-267.9M-365.7M-376.8M-1.3B
 
 
 
 
 
Income Taxes-118.5M-7.2M-72.8M-113.3M
 
 
 
 
 
Minority Interest-500.0K-800.0K-1.7M-700.0K
 
 
 
 
 
Net Income-385.9M-373.7M-302.3M-1.2B
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS344.9M344.9M345.0M349.5M
 
 
 
 
 
Shares To Calculate EPS Diluted344.9M344.9M345.0M349.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.12-$1.08-$0.88-$3.49
 
 
 
 
 
EPS Diluted-$1.12-$1.08-$0.88-$3.49